Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

NICE wants more data on Alexion’s orphan drug Kanuma

Calls for 'robust evidence' about the costly rare disease treatment's price and benefits

- PMLiVE

Stem cell therapy promising for rheumatoid arthritis

Mesoblast’s phase II trial sees "impressive efficacy" in refractory patients

- PMLiVE

The hidden costs of poor translation

How to ensure that outsourcing really adds up to cost-saving

- PMLiVE

The EMA’s literature screening service and pharma

Complexities and new potential in pharmacovigilance

- PMLiVE

A five-step plan for patient-centred digital communications

Every functional area should be able to interact with patients

- PMLiVE

Changing the game in multichannel marketing

Blowing the whistle on pharma’s road to the new normal

- PMLiVE

Reflections on marketing excellence

Looking back over 20 years of change in pharma marketing

Deal Watch January 2016

Shire, Roche, Sanofi, BMS and Merck & Co are among those featured in this month's roundup of M&A and other pharma deal activity

- PMLiVE

Daiichi Sankyo collaborates on e-patient AF resource

Will work with European platform People Who on new illness profile

- PMLiVE

Biogen targets ‘lost to follow-up’ patients in MS campaign

Biotech company's 1MSg initiative will provide a range of educational materials

The future of Pfizer(s)

Current headlines point to a frightening journey

- PMLiVE

Pfizer settles US Protonix lawsuit for $785m

US government deal covers Wyeth’s failure to pay drug rebates

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links